Description

Due to the limitation of current pharmacological therapeutic strategies, stem cell therapies have emerged as a viable option for treating many incurable neurological disorders. Specifically, human pluripotent stem cell (hPSC)-derived

Due to the limitation of current pharmacological therapeutic strategies, stem cell therapies have emerged as a viable option for treating many incurable neurological disorders. Specifically, human pluripotent stem cell (hPSC)-derived neural progenitor cells (hNPCs), a multipotent cell population that is capable of near indefinite expansion and subsequent differentiation into the various cell types that comprise the central nervous system (CNS), could provide an unlimited source of cells for such cell-based therapies.

Reuse Permissions
  • application/pdf

    Download count: 0

    Details

    Contributors
    Date Created
    • 2015-05-13
    Resource Type
  • Text
  • Collections this item is in
    Identifier
    • Digital object identifier: 10.1016/j.scr.2015.05.002
    • Identifier Type
      International standard serial number
      Identifier Value
      1873-5061
    • Identifier Type
      International standard serial number
      Identifier Value
      1876-7753

    Citation and reuse

    Cite this item

    This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.

    Tsai, Y., Cutts, J., Kimura, A., Varun, D., & Brafman, D. A. (2015). A chemically defined substrate for the expansion and neuronal differentiation of human pluripotent stem cell-derived neural progenitor cells. Stem Cell Research, 15(1), 75-87. doi:10.1016/j.scr.2015.05.002

    Machine-readable links